Benefits
Sarcopenia 24-week RCT in elderly (PIVOTAL)
Susan/Gillian/Bonnet/Donovan 2021 (JOJ Case Stud 12(5):555850) — sarcopenia 24-week RCT at 15 g/day Naticol® in elderly. Significantly improved sarcopenia symptoms with increased lean muscle mass, handgrip strength, Short Physical Performance Battery, and Chair Stand Test. Multi-functional outcomes important for healthy aging — addresses the major clinical concerns in age-related muscle loss.
Skin aging 12-week LOW-DOSE RCT (Naticol-Cyskin)
Skin aging 12-week RCT in 57 mature women at 2.5 g/day Naticol or Naticol-Cyskin. Reduced visible signs of aging including wrinkles, fine lines, and dry skin. Demonstrating clinical efficacy at lower dose than typical 5-10 g collagen products — practical advantage for product formulation in functional foods and beverages.
Weight management 3-month RCT (NCT03872297)
NCT03872297 NATICOL Trial — Institut Pasteur de Lille. 3-month quadruple-masked weight management RCT in overweight volunteers. Status: completed. Emerging weight management indication — adds to the multi-domain evidence base beyond classic skin and joint applications.
Joint health and osteoarthritis (clinical evidence)
Joint comfort general support evidence per Weishardt research base — consistent with the broader collagen peptide joint health framework. Smaller-scale evidence for joint-specific indications relative to the strong sarcopenia and skin RCTs.
Sustainable circular economy upcycling
Weishardt upcycles fish skins discarded by the fish fillet industry into a premium value-added product. Sustainable species sourced. Distinguishing positioning increasingly relevant to environmentally-conscious consumers and regulatory sustainability frameworks.
Premium organoleptic profile
Neutral odor, neutral taste, colorless, water-soluble, heat-resistant. Distinguishing formulation features for functional beverages, hot drinks, sachets, capsules, and soft gels. Major advantage over typical fish collagens which often carry residual fishy taste or odor that limits formulation options.
High protein purity (>99% on dry matter)
>99% protein content on dry matter — among the purest collagen peptides on market. Reflects the proprietary enzymatic hydrolysis process and quality control.
Mechanism of action
Type I collagen peptide bioavailability
Specific molecular weight peptide profile via gentle enzymatic hydrolysis enables high bioavailability and rapid absorption. Type I collagen is the primary structural collagen in skin, bone, tendon, and most connective tissues — relevance to skin and joint applications.
Amino acid pool for collagen synthesis
Provides glycine, proline, and hydroxyproline — the characteristic collagen amino acids — as substrate for endogenous collagen synthesis.
Specific peptide bioactivity
Beyond pure amino acid provision, specific di- and tripeptides (Pro-Hyp, Hyp-Gly) directly stimulate fibroblasts and chondrocytes. The bioactivity goes beyond simple protein nutrition.
MMP inhibition (matrix metalloproteinase)
Matrix metalloproteinase suppression contributes to skin and joint matrix preservation. Reduces degradation of existing collagen alongside supporting new synthesis.
Muscle protein synthesis stimulation
Mechanism for the sarcopenia trial outcomes — the amino acid pool plus specific peptide bioactivity stimulate muscle protein synthesis in the elderly population.
Marine collagen distinction from bovine/porcine
Marine type I collagen differs from bovine or porcine collagen in molecular weight distribution and amino acid profile. Avoids mammalian-source concerns (BSE, religious dietary restrictions) and offers different absorption kinetics.
Clinical trials
Susan/Gillian/Bonnet/Donovan 2021 (JOJ Case Stud 12(5):555850). 24-week RCT at 15 g/day Naticol® in elderly. Significantly improved sarcopenia symptoms with increased lean muscle mass, handgrip strength, Short Physical Performance Battery, and Chair Stand Test. Multi-functional healthy aging outcomes.
12-week RCT in 57 mature women at 2.5 g/day Naticol or Naticol-Cyskin. Reduced visible signs of aging (wrinkles, fine lines, dry skin) at lower dose than typical 5-10 g collagen products.
NCT03872297 NATICOL Trial — Institut Pasteur de Lille. 3-month quadruple-masked weight management RCT in overweight volunteers. Status: completed. Emerging weight management indication.